BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7907870)

  • 1. Inhibitory effect of idazoxan on forskolin-stimulated adenylate cyclase activity through 5-hydroxytryptamine1A receptors.
    Kawai N; Yamamoto T; Baba A; Yamamoto H; Moroji T
    Arzneimittelforschung; 1994 Jan; 44(1):1-3. PubMed ID: 7907870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
    Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; Vallgårda J; Hacksell U; Nelson DL
    Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats.
    Clarke WP; Yocca FD; Maayani S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1259-66. PubMed ID: 8667186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants.
    Newman ME; Shapira B; Lerer B
    J Pharmacol Exp Ther; 1992 Jan; 260(1):16-20. PubMed ID: 1530973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
    de Boer TH; Nefkens F; van Helvoirt A; van Delft AM
    J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine].
    Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP
    Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination.
    Winter JC; Rabin RA
    J Pharmacol Exp Ther; 1992 Nov; 263(2):682-9. PubMed ID: 1359109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
    Bervoets K; Millan MJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):110-20. PubMed ID: 7909554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture.
    Nash MS; Osborne NN
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):510-9. PubMed ID: 9040484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
    De Vivo M; Maayani S
    J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
    Schoeffter P; Hoyer D
    Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists.
    Devivo M; Maayani S
    Eur J Pharmacol; 1985 Dec; 119(3):231-4. PubMed ID: 2936612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of forskolin stimulated adenylate cyclase in rat hippocampus as a screen for compounds that act through 5-HT1A receptors.
    Cornfield LJ; Nelson DL; Monroe PJ; Taylor EW; Nikam SS
    Proc West Pharmacol Soc; 1988; 31():265-7. PubMed ID: 3211913
    [No Abstract]   [Full Text] [Related]  

  • 20. alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
    Zhang W; Klimek V; Farley JT; Zhu MY; Ordway GA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1286-92. PubMed ID: 10336518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.